Regarding type II interferons, some studies have demonstrated elevated IFNG mRNA levels and IFNγ targets in the blood and skin lesions from SLE patients (Carneiro et al., 2011; Karonitsch et al., 2009; Lit et al., 2007). The gene discussed is IFNG; the disease is systemic lupus erythematosus.